Rankings
▼
Calendar
SCYX Q2 2025 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
Q2 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1M
+85.3% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$10M
-701.0% margin
Net Income
-$7M
-504.8% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+430.7%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$820,000
Balance Sheet
Total Assets
$61M
Total Liabilities
$16M
Stockholders' Equity
$44M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$736,000
+85.3%
Gross Profit
$1M
$736,000
+85.3%
Operating Income
-$10M
-$9M
-3.5%
Net Income
-$7M
-$14M
+52.4%
Revenue Segments
License and Service
$1M
100%
← FY 2025
All Quarters
Q3 2025 →